2015
Overview
Hematology-oncology research is the study of blood, blood-forming tissues, and cancer, uniting the closely connected fields of hematology, the science of blood and its disorders, and oncology, the science of cancer. It encompasses both benign blood conditions, such as anemias and bleeding and clotting disorders, and malignant diseases, including leukemias, lymphomas, and other cancers, as well as the supportive care of patients undergoing cancer treatment. The field investigates the cellular and molecular mechanisms that drive blood and cancer disorders, develops and refines diagnostic methods, and advances treatments ranging from chemotherapy and targeted drugs to immunotherapy and stem cell transplantation. Because blood cells and the immune system are intimately involved in both normal physiology and cancer, hematology and oncology are studied together, and research in this area aims to improve the detection, treatment, and outcomes of some of the most serious diseases worldwide. Research relevant to this topic in Hematology and Oncology Research includes work on managing invasive fungal infection in a hematology ward, pain and depression in patients with sickle cell disease, and abnormalities of clotting factors in aggressive hematological malignancies, reflecting the journal's coverage of both blood disorders and cancer. This page gathers peer-reviewed, open-access research relevant to hematology and oncology.
Research published in this journal
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
2014
2015
How this research is being cited
The 3 articles above have been cited 3 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Journal of the National Medical Association
-
Dina Ashraf Abdelhady et al. · 2025 · European Journal of Medical Research
-
2025 · European journal of medical research
A sample of recent works citing this journal's research on Hematology-oncology Research, linking to each citing work.